Handelsbanken Fonder’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Sell |
32,623
-4,900
| -13% | -$87.3K | ﹤0.01% | 1185 |
|
|
2025
Q1 | $669K | Hold |
37,523
| – | – | ﹤0.01% | 1126 |
|
|
2024
Q4 | $1.12M | Buy |
37,523
+3,300
| +10% | +$98.3K | ﹤0.01% | 921 |
|
|
2024
Q3 | $535K | Buy |
34,223
+5,000
| +17% | +$78.2K | ﹤0.01% | 1214 |
|
|
2024
Q2 | $501K | Buy |
29,223
+7,100
| +32% | +$122K | ﹤0.01% | 1155 |
|
|
2024
Q1 | $346K | Hold |
22,123
| – | – | ﹤0.01% | 1331 |
|
|
2023
Q4 | $330K | Sell |
22,123
-12,523
| -36% | -$187K | ﹤0.01% | 1346 |
|
|
2023
Q3 | $560K | Buy |
34,646
+17,323
| +100% | +$280K | ﹤0.01% | 1001 |
|
|
2023
Q2 | $719K | Buy |
17,323
+1,800
| +12% | +$74.7K | ﹤0.01% | 881 |
|
|
2023
Q1 | $934K | Hold |
15,523
| – | – | 0.01% | 718 |
|
|
2022
Q4 | $1.14M | Buy |
15,523
+400
| +3% | +$29.4K | 0.01% | 618 |
|
|
2022
Q3 | $1.15M | Hold |
15,123
| – | – | 0.01% | 621 |
|
|
2022
Q2 | $1.05M | Buy |
15,123
+1,000
| +7% | +$69.5K | 0.01% | 671 |
|
|
2022
Q1 | $1.17M | Sell |
14,123
-2,000
| -12% | -$166K | 0.01% | 730 |
|
|
2021
Q4 | $1.21M | Buy |
+16,123
| New | +$1.21M | 0.01% | 798 |
|
|
2021
Q3 | – | Sell |
-15,723
| Closed | -$3.49M | – | 1689 |
|
|
2021
Q2 | $3.49M | Buy |
+15,723
| New | +$3.49M | 0.02% | 536 |
|
|
2021
Q1 | – | Sell |
-15,923
| Closed | -$2.76M | – | 1580 |
|
|
2020
Q4 | $2.76M | Buy |
+15,923
| New | +$2.76M | 0.02% | 541 |
|